124 RANDOMIZED PHASE II CLINICAL TRIAL OF INTRATUMORAL INJECTION OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Autor: Heo, J., Reid, T., Lim, H.Y., Ruo, L., Kim, C.W., Bloomston, M., Chung, H.C., Rhee, B.G., Patt, R., Breitbach, C.J., Hickman, T., Bell, J.C., Hwang, T.H., Kirn, D.H.
Zdroj: In Journal of Hepatology 2010 52 Supplement 1:S55-S55
Databáze: ScienceDirect